SKLB610, a novel multi-targeted inhibitor, inhibits angiogenesis-related tyrosine kinase VEGFR2, FGFR2 and PDGFR at rate of 97%, 65% and 55%, respectively, at concentration of 10 M in biochemical kinase assays
仅供研究使用。 我们不向患者出售。
化学信息
名称 | SKLB610 |
分子式 | C21H16F3N3O3 |
分子量 | 415.37 |
InChiKey | |
InChi | |
Cas号 | 1125780-41-7 |
相关CAS号 | |
Targets | |
Mechanism | |
Cell study | |
Animal study | |
Clinical study | |